Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,478 | 280 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $1,254 | 59 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,151 | 57 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $852.97 | 58 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $377.03 | 12 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $321.35 | 12 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $252.87 | 13 | $0 (2022) |
| ITI, Inc. | $248.03 | 10 | $0 (2023) |
| Lundbeck LLC | $223.18 | 15 | $0 (2022) |
| Neos Therapeutics, LP | $206.14 | 14 | $0 (2023) |
| Bausch Health US, LLC | $194.78 | 10 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $130.62 | 1 | Janssen Pharmaceuticals, Inc ($130.62) |
| 2023 | $478.66 | 24 | AbbVie Inc. ($184.82) |
| 2022 | $1,751 | 91 | ABBVIE INC. ($578.02) |
| 2021 | $2,726 | 147 | Takeda Pharmaceuticals U.S.A., Inc. ($825.63) |
| 2020 | $391.67 | 17 | Takeda Pharmaceuticals U.S.A., Inc. ($135.22) |
All Payment Transactions
280 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/27/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $130.62 | General |
| Category: Neuroscience | ||||||
| 11/09/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: NEUROSCIENCE | ||||||
| 08/30/2023 | Bausch Health US, LLC | APLENZIN (Drug), WELLBUTRIN | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Neurology | ||||||
| 08/23/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.24 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2023 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: ADHD | ||||||
| 08/01/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2023 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: ADHD | ||||||
| 07/20/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.75 | General |
| Category: NEUROSCIENCE | ||||||
| 07/20/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.52 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2023 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $21.37 | General |
| Category: ADHD | ||||||
| 07/06/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $34.92 | General |
| Category: Central Nervous System | ||||||
| 06/20/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.98 | General |
| Category: NEUROSCIENCE | ||||||
| 06/07/2023 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $19.10 | General |
| Category: ADHD | ||||||
| 06/06/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.92 | General |
| Category: NEUROSCIENCE | ||||||
| 05/31/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: PSYCHIATRY | ||||||
| 05/10/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.56 | General |
| Category: NEUROSCIENCE | ||||||
| 05/03/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: NEUROSCIENCE | ||||||
| 01/25/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $29.07 | General |
| Category: NEUROSCIENCE | ||||||
| 01/24/2023 | Noven Therapeutics, LLC | Secuado (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: CNS Psychiatry | ||||||
| 01/18/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: NEUROSCIENCE | ||||||
| 01/17/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Psychology/Psychiatric | ||||||
| 01/16/2023 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: ADHD | ||||||
| 01/11/2023 | Almatica Pharma LLC | SERTRALINE HCL (Drug), LOREEV XR | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: ANTI-DEPRESSION | ||||||
| 01/10/2023 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 01/04/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 29 | 186 | $36,363 | $14,585 |
| 2022 | 2 | 36 | 164 | $32,848 | $11,489 |
| 2021 | 1 | 12 | 43 | $5,590 | $2,412 |
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 93 | $24,273 | $9,484 | 39.1% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 15 | 93 | $12,090 | $5,101 | 42.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 88 | $22,968 | $7,444 | 32.4% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 18 | 76 | $9,880 | $4,045 | 40.9% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 12 | 43 | $5,590 | $2,412 | 43.1% |
About Dr. Michael Swiatkowski, D.O
Dr. Michael Swiatkowski, D.O is a Psychiatry healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2016. The National Provider Identifier (NPI) number assigned to this provider is 1891157178.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Swiatkowski, D.O has received a total of $5,478 in payments from pharmaceutical and medical device companies, with $130.62 received in 2024. These payments were reported across 280 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($5,478).
As a Medicare-enrolled provider, Swiatkowski has provided services to 77 Medicare beneficiaries, totaling 393 services with total Medicare billing of $28,486. Data is available for 3 years (2021–2023), covering 5 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Chicago, IL
- Active Since 03/24/2016
- Last Updated 04/15/2025
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1891157178
Products in Payments
- VRAYLAR (Drug) $1,272
- TRINTELLIX (Drug) $1,151
- LATUDA (Drug) $852.97
- REXULTI (Drug) $378.86
- SPRAVATO (Drug) $359.91
- HETLIOZ (Drug) $321.35
- CAPLYTA (Drug) $248.03
- Adzenys XR-ODT (Drug) $206.14
- APLENZIN (Drug) $160.95
- BRINTELLIX (Drug) $97.19
- Dyanavel XR (Drug) $70.44
- Auvelity (Drug) $46.71
- ADHANSIA XR (Drug) $35.54
- Austedo XR (Drug) $34.92
- QELBREE (Drug) $34.76
- WELLBUTRIN (Drug) $33.83
- AUSTEDO (Drug) $20.49
- GRALISE (Drug) $20.22
- Secuado (Drug) $18.44
- NURTEC ODT (Drug) $18.14
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Chicago
Dr. Michelle Dees, Md, MD
Psychiatry — Payments: $523,545
Mitchell Glaser, Md, MD
Psychiatry — Payments: $494,195
Peter Weiden, Md, MD
Psychiatry — Payments: $202,917
Emil Coccaro, M.d, M.D
Psychiatry — Payments: $104,905
Jon Grant
Psychiatry — Payments: $86,379
Dr. Richard Baer, M.d, M.D
Psychiatry — Payments: $84,125